MeiraGTx

MGTXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.256 B

$13.08 -1.28%

Close of 21 Sept 2026

Revenue

$81.4M

#2575 by revenue

Earnings

—

Not reported

Shares outstanding

96,042,996

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#43ImmaticsIMTX$1.30B
#44Vor BiopharmaVOR$1.30B
#45MeiraGTxMGTX$1.26B
#46Maze TherapeuticsMAZE$1.24B
#47Replimune GroupREPL$1.21B

What if MeiraGTx were worth as much as…

Open the what-if tool →

Gold $30.3T

$315,213.55

Per share 24,099× higher

Bitcoin $1.72T

$17,906.60

Per share 1,369× higher

Nvidia $5.48T

$57,056.30

Per share 4,362× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for MeiraGTx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.